AAAAAA

   
Results: 1-11 |
Results: 11
IMPACT OF PHARMACIST CONSULTATIONS PROVIDED TO PATIENTS WITH DIABETESON HEALTH-CARE COSTS IN A HEALTH MAINTENANCE ORGANIZATION
Authors: GERBER RA LIU G MCCOMBS JS
Citation: Ra. Gerber et al., IMPACT OF PHARMACIST CONSULTATIONS PROVIDED TO PATIENTS WITH DIABETESON HEALTH-CARE COSTS IN A HEALTH MAINTENANCE ORGANIZATION, American journal of managed care, 4(7), 1998, pp. 991-1000
FACTORS AFFECTING PATIENT COMPLIANCE WITH ANTIHYPERLIPIDEMIC MEDICATIONS IN AN HMO POPULATION
Authors: SUNG JCY NICHOL MB VENTURINI F BAILEY KL MCCOMBS JS CODY M
Citation: Jcy. Sung et al., FACTORS AFFECTING PATIENT COMPLIANCE WITH ANTIHYPERLIPIDEMIC MEDICATIONS IN AN HMO POPULATION, American journal of managed care, 4(10), 1998, pp. 1421-1430
PHARMACOECONOMICS - WHAT IS IT AND WHERE IS IT GOING
Authors: MCCOMBS JS
Citation: Js. Mccombs, PHARMACOECONOMICS - WHAT IS IT AND WHERE IS IT GOING, American journal of hypertension, 11(8), 1998, pp. 112-119
PANEL DISCUSSION 2
Authors: MOSER M MCCOMBS JS",CUSHMAN,"BLACK HR MATERSON B",JACKSON
Citation: M. Moser et al., PANEL DISCUSSION 2, American journal of hypertension, 11(8), 1998, pp. 135-137
THE COST OF TREATING COMMUNITY-ACQUIRED PNEUMONIA
Authors: NIEDERMAN MS MCCOMBS JS UNGER AN KUMAR A POPOVIAN R
Citation: Ms. Niederman et al., THE COST OF TREATING COMMUNITY-ACQUIRED PNEUMONIA, Clinical therapeutics, 20(4), 1998, pp. 820-837
FACTORS AFFECTING PATIENT COMPLIANCE WITH ANTIHYPERLIPIDEMIC MEDICATIONS IN AN HMO POPULATION
Authors: SUNG JCY NICHOL MB VENTURINI F BAILEY KL MCCOMBS JS CODY M
Citation: Jcy. Sung et al., FACTORS AFFECTING PATIENT COMPLIANCE WITH ANTIHYPERLIPIDEMIC MEDICATIONS IN AN HMO POPULATION, American journal of managed care, 3(10), 1997, pp. 16-16
COST-EFFECTIVENESS ANALYSIS AND BUDGET CONSTRAINTS
Authors: MCCOMBS JS
Citation: Js. Mccombs, COST-EFFECTIVENESS ANALYSIS AND BUDGET CONSTRAINTS, The New England journal of medicine, 335(19), 1996, pp. 1465-1465
THE USE OF FIRST-LINE AND 2ND-LINE OUTPATIENT ANTIBIOTICS UNDER THE SASKATCHEWAN DRUG PLAN
Authors: MCCOMBS JS NICHOL MB
Citation: Js. Mccombs et Mb. Nichol, THE USE OF FIRST-LINE AND 2ND-LINE OUTPATIENT ANTIBIOTICS UNDER THE SASKATCHEWAN DRUG PLAN, PharmacoEconomics, 7(6), 1995, pp. 543-554
IS PHARMACY VISION OF THE FUTURE TOO NARROW
Authors: MCCOMBS JS NICHOL MB JOHNSON KA HAY JW EBIN VJ LAWRENCE GD SCHNEIDER JS
Citation: Js. Mccombs et al., IS PHARMACY VISION OF THE FUTURE TOO NARROW, American journal of health-system pharmacy, 52(11), 1995, pp. 1208-1214
MEASURING THE IMPACT OF PATIENT COUNSELING IN THE OUTPATIENT PHARMACYSETTING - THE RESEARCH DESIGN OF THE KAISER-PERMANENTE USC PATIENT CONSULTATION STUDY
Authors: MCCOMBS JS CODY M BESINQUE K BOROK G ERSHOFF D GROSHEN S HAY J JOHNSON KA NICHOL MB NYE MT
Citation: Js. Mccombs et al., MEASURING THE IMPACT OF PATIENT COUNSELING IN THE OUTPATIENT PHARMACYSETTING - THE RESEARCH DESIGN OF THE KAISER-PERMANENTE USC PATIENT CONSULTATION STUDY, Clinical therapeutics, 17(6), 1995, pp. 1188-1206
THE COSTS OF INTERRUPTING ANTIHYPERTENSIVE DRUG-THERAPY IN A MEDICAIDPOPULATION
Authors: MCCOMBS JS NICHOL MB NEWMAN CM SCLAR DA
Citation: Js. Mccombs et al., THE COSTS OF INTERRUPTING ANTIHYPERTENSIVE DRUG-THERAPY IN A MEDICAIDPOPULATION, Medical care, 32(3), 1994, pp. 214-226
Risultati: 1-11 |